Los Angeles Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.46M	Buy	272,776 +254,467	+1,390%	+$4.02M	0.01%	458
2025 Q4	$280K	Hold	18,309	–	–	﹤0.01%	1124
2025 Q3	$268K	Sell	18,309 -53,065	-74%	-$910K	﹤0.01%	1168
2025 Q2	$1.3M	Sell	71,374 -51,670	-42%	-$1.05M	﹤0.01%	579
2025 Q1	$2.44M	Buy	123,044 +39,804	+48%	+$688K	0.01%	371
2024 Q4	$1.43M	Sell	83,240 -65,250	-44%	-$1.23M	0.01%	524
2024 Q3	$2.97M	Buy	148,490 +67,740	+84%	+$1.05M	0.01%	387
2024 Q2	$903K	Buy	+80,750	New	+$677K	﹤0.01%	685
2021 Q3	–	Sell	-37,165	Closed	-$59K	–	1462
2021 Q2	$59K	Sell	37,165 -2,100	-5%	-$3.69K	﹤0.01%	1516
2021 Q1	$69K	Sell	39,265 -34,100	-46%	-$78K	﹤0.01%	1570
2020 Q4	$143K	Buy	73,365 +50	+0.1%	+$105	﹤0.01%	1489
2020 Q3	$175K	Sell	73,315 -9,830	-12%	-$27K	﹤0.01%	1403
2020 Q2	$244K	Buy	83,145 +57,010	+218%	+$164K	﹤0.01%	1344
2020 Q1	$75K	Buy	+26,135	New	+$90.3K	﹤0.01%	1310